Texas Oncology Midtown — Dallas, Texas

Texas Oncology Midtown is a clinical research site located in Dallas, Texas, United States 75251.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Texas Oncology Midtown has participated in 1 clinical trials.

Therapeutic areas: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Midtown?

Texas Oncology Midtown has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Midtown conducted?

Texas Oncology Midtown has 1 clinical trials on record. Their work covers HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.

Is Texas Oncology Midtown accredited by Crixeo Health?

Texas Oncology Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.